Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",23237,82,0.85 [0.54-1.32],0.4627304848354261
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23724,127,0.82 [0.57-1.18],0.2839570822472428
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23511,866,0.91 [0.80-1.03],0.1433214039815137
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Candidiasis,23745,257,1.14 [0.95-1.36],0.1477142597246348
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23067,2333,0.98 [0.91-1.05],0.6154299519521953
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23283,1753,0.93 [0.85-1.01],0.0990160904761101
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23575,845,0.97 [0.87-1.10],0.6767865901187279
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23680,38,0.82 [0.43-1.58],0.5600280388147236
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22664,541,0.88 [0.75-1.04],0.1258000848709818
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21897,512,0.89 [0.76-1.06],0.1892568133917781
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,22118,145,1.09 [0.84-1.40],0.5253396098692036
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,17637,1021,0.94 [0.84-1.06],0.3421299982762208
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21919,244,1.03 [0.83-1.27],0.7873408753358799
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23717,987,0.99 [0.88-1.10],0.8112597843099514
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Mycoses,23800,312,1.09 [0.92-1.30],0.3119842127913518
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23169,524,1.00 [0.86-1.15],0.9479579353798282
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23749,594,0.89 [0.76-1.04],0.1469389049039188
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22859,129,0.82 [0.57-1.17],0.2715747894114509
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23842,28,1.08 [0.59-1.95],0.8097596673712769
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Other septicaemia,23676,521,0.90 [0.77-1.07],0.2308543685223704
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23706,64,0.84 [0.51-1.39],0.5004184378799401
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Other viral diseases,23752,150,1.09 [0.85-1.39],0.5182733836429543
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23737,135,1.11 [0.86-1.42],0.4391233705361944
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22944,299,0.81 [0.64-1.03],0.0876555481094945
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22847,202,0.82 [0.62-1.09],0.1742199798262454
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22794,64,1.28 [0.93-1.76],0.1343393512882983
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23815,45,1.10 [0.69-1.77],0.6829636379969117
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23786,110,0.78 [0.53-1.17],0.2323513679532845
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Viral warts,23711,35,0.78 [0.38-1.60],0.4961665862326639
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23719,43,0.52 [0.24-1.15],0.1053687418188181
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign lipomatous neoplasm,23591,273,0.98 [0.79-1.21],0.8473364304776597
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23767,63,0.73 [0.42-1.26],0.2562413472301819
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23739,68,1.37 [1.04-1.80],0.023530241236099
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,10623,38,0.85 [0.43-1.66],0.6264623805688931
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23671,988,0.95 [0.85-1.06],0.3702799215835488
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm of meninges,23830,43,0.81 [0.43-1.50],0.4949634146210319
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23810,46,0.60 [0.29-1.23],0.1647062390124644
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23822,75,1.03 [0.70-1.51],0.8780773658711429
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm of ovary,13162,84,0.92 [0.63-1.36],0.6896307847563375
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm: Ascending colon,23833,230,0.93 [0.73-1.19],0.5756992633686422
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm: Caecum,23830,171,0.82 [0.60-1.13],0.2252004418051396
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23778,44,1.10 [0.69-1.76],0.679248883887009
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm: Descending colon,23838,149,0.94 [0.69-1.26],0.6661037210941572
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm: Rectum,23805,243,0.96 [0.76-1.21],0.7186777615883129
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23773,460,1.07 [0.92-1.24],0.3696482664616313
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm: Transverse colon,23834,256,0.98 [0.78-1.22],0.836120708257444
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Carcinoma in situ of breast,11311,73,0.69 [0.41-1.16],0.1634486794993266
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",11347,80,0.54 [0.31-0.95],0.0321496474776617
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",20590,31,0.63 [0.26-1.52],0.3011523915690251
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",20592,33,1.16 [0.69-1.93],0.5796259297414705
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23802,92,1.29 [1.00-1.67],0.0472247071081366
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Haemangioma, any site",23802,90,1.30 [1.00-1.67],0.0466402533433749
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Leiomyoma of uterus,12613,341,1.02 [0.86-1.22],0.7896598121973252
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Lung cancer and mesothelioma,17649,152,0.90 [0.65-1.24],0.518062905930391
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Lymphoid leukaemia,20586,27,0.66 [0.26-1.64],0.3665128650951431
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",20686,127,1.28 [1.03-1.60],0.0286863527374448
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",20634,75,1.32 [1.00-1.76],0.0501915894252881
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",11396,68,1.20 [0.88-1.64],0.2521807180511374
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",20603,44,0.90 [0.51-1.61],0.723559582849743
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",20606,47,1.25 [0.84-1.84],0.2734292518795317
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",20620,61,1.07 [0.70-1.65],0.746036721972309
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",11376,48,1.14 [0.76-1.70],0.5325402955017955
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",20610,51,0.82 [0.46-1.46],0.4975253960739276
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",9574,343,0.99 [0.81-1.21],0.933633775822574
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",20643,84,0.99 [0.67-1.45],0.956529730942674
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",20605,46,0.76 [0.40-1.46],0.4132094160472561
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,20613,54,1.44 [1.09-1.92],0.0111967959858774
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Melanocytic naevi,23636,190,0.85 [0.64-1.12],0.2473210842912477
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Melanocytic naevi of trunk,23799,86,1.01 [0.70-1.45],0.9688283847733028
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Melanoma in situ,20569,40,1.15 [0.73-1.82],0.5470400579837977
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",20612,53,1.08 [0.69-1.68],0.7343611509870548
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",20657,98,1.00 [0.70-1.42],0.9821305124795556
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",20659,100,0.89 [0.59-1.34],0.5675577141651709
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",20616,57,1.01 [0.64-1.58],0.9730571528388005
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Other benign neoplasms of skin,23686,123,1.22 [0.96-1.55],0.1094111698643384
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",21105,546,1.05 [0.92-1.21],0.4539470528779287
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",21132,573,1.07 [0.94-1.22],0.3107627988543451
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23588,262,1.13 [0.94-1.35],0.1868045814898835
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,22618,40,0.66 [0.32-1.38],0.2716845039291883
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23392,66,0.96 [0.62-1.50],0.8704897089717409
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23141,1914,0.99 [0.92-1.07],0.8513662678712918
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22841,19,0.34 [0.09-1.36],0.1288903347235945
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23535,28,0.61 [0.24-1.55],0.2979754226192057
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23458,880,1.00 [0.89-1.12],0.996021141313421
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23458,880,1.00 [0.89-1.12],0.996021141313421
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,22626,48,0.91 [0.54-1.55],0.732113017350158
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23602,780,1.07 [0.96-1.20],0.2360259217497415
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23600,93,0.89 [0.60-1.32],0.5779758680110354
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23374,48,1.08 [0.69-1.68],0.7337775349291575
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23365,39,1.04 [0.62-1.74],0.8912323021435936
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23673,166,0.91 [0.68-1.21],0.5077926900428879
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23773,59,0.88 [0.53-1.44],0.6006562159909372
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23650,143,1.04 [0.79-1.36],0.7840171737541894
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22881,59,1.12 [0.76-1.65],0.5538859179952562
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,20457,176,0.91 [0.68-1.21],0.5112672246135473
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22151,103,0.98 [0.71-1.36],0.9138800796788502
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22169,121,1.17 [0.90-1.52],0.2468832210481539
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,20313,32,0.80 [0.39-1.65],0.5536727409777387
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22116,60,0.69 [0.38-1.25],0.2170357569605588
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21816,120,0.94 [0.68-1.31],0.7230765570263776
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23717,143,0.72 [0.49-1.04],0.0829143599850848
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,23619,45,1.01 [0.62-1.65],0.9692656386291776
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,23606,32,0.73 [0.33-1.59],0.4258608006668842
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23493,1437,0.96 [0.88-1.06],0.4387401246562549
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,21346,1397,0.97 [0.88-1.06],0.49793377252588
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",20318,37,0.83 [0.62-1.12],0.227439152383344
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",22434,51,0.85 [0.49-1.47],0.5508806204095198
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,20440,159,0.98 [0.74-1.28],0.8586304540744001
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,20336,55,0.55 [0.28-1.08],0.0826740352489881
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,22355,2074,0.98 [0.91-1.06],0.5843596496762453
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,20382,101,0.89 [0.61-1.29],0.5279056372150082
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,20613,332,0.91 [0.74-1.11],0.360619155701497
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23761,225,0.95 [0.75-1.20],0.6709831997576525
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23627,91,0.92 [0.63-1.35],0.6699804678192198
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,20365,84,1.08 [0.77-1.52],0.6370493098906085
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",20315,34,0.75 [0.36-1.58],0.4558869170927502
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23477,1094,0.99 [0.89-1.10],0.8546875956156184
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,20393,112,1.12 [0.85-1.48],0.4246935433396543
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,20412,131,1.03 [0.77-1.38],0.8340460110937252
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",20624,343,1.02 [0.85-1.22],0.8464243588966305
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,20334,53,0.61 [0.31-1.20],0.1521018095931686
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23621,85,0.93 [0.62-1.37],0.698629247795645
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,20536,255,0.96 [0.77-1.20],0.7253411714842504
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,20549,268,1.03 [0.85-1.25],0.7680391336949794
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21747,51,1.38 [1.01-1.90],0.046510821248808
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23238,2957,0.97 [0.91-1.03],0.2970341045547606
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,22407,24,0.73 [0.30-1.77],0.4843818141850801
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,22436,53,0.63 [0.33-1.20],0.1583882339224889
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23686,1675,1.02 [0.94-1.10],0.698611238519496
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23689,1672,1.02 [0.94-1.11],0.6779975174019068
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,22414,31,0.75 [0.35-1.61],0.4536163634162464
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23564,1068,1.02 [0.93-1.13],0.6440361660817617
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",21050,769,1.00 [0.89-1.13],0.944476425594296
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23834,102,0.80 [0.52-1.21],0.2862887758169007
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,23603,29,1.13 [0.65-1.98],0.6571675689997807
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22575,79,1.10 [0.79-1.55],0.5687131027978634
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22593,97,1.15 [0.86-1.54],0.3609321769699906
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",20391,110,0.85 [0.59-1.22],0.3830295538646463
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22281,103,1.22 [0.94-1.60],0.1401032003402715
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1478,58,0.79 [0.46-1.38],0.411907845500208
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1575,168,0.97 [0.73-1.30],0.8526928775004103
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,22212,34,0.66 [0.29-1.50],0.3241846046569108
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1449,29,0.98 [0.49-1.97],0.9562798528228064
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23484,1306,0.99 [0.90-1.09],0.825316015426174
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23632,58,0.88 [0.53-1.45],0.6065303973917434
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21937,241,0.89 [0.70-1.14],0.3523413960585637
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,20622,341,0.89 [0.73-1.09],0.2669767597484642
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23764,148,0.72 [0.50-1.04],0.0786272602843605
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),23186,48,1.12 [0.73-1.73],0.5992936557370481
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Angina pectoris,22740,692,0.92 [0.80-1.06],0.2422469950316941
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Aortic aneurysm,23229,91,1.24 [0.94-1.64],0.1321299917288333
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,23168,30,1.04 [0.57-1.88],0.9069143765832818
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",23234,96,0.97 [0.67-1.39],0.8625004629285791
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,16918,787,0.97 [0.85-1.10],0.6459345838408628
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,AV-block,21689,158,0.87 [0.64-1.19],0.3874485323534258
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23812,224,0.79 [0.59-1.04],0.0940267306477088
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Cardiac arrest,16226,95,0.78 [0.50-1.21],0.2602757500888343
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Cardiomyopathy,21642,111,0.87 [0.60-1.27],0.4678986187190512
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",21602,71,1.00 [0.67-1.51],0.9859104910171684
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23844,15,1.05 [0.45-2.46],0.9093476505978684
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Conduction disorders,21991,460,0.94 [0.79-1.11],0.4484340531875779
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,23204,1166,0.96 [0.87-1.07],0.4942232876295033
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Death due to cardiac causes,22147,5244,1.01 [0.97-1.06],0.601205842835379
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,DVT of lower extremities,22845,156,0.77 [0.55-1.09],0.1373352388187301
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Endocarditis,21570,39,0.76 [0.39-1.51],0.436948563752602
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Heart failure, strict",23735,444,1.09 [0.94-1.26],0.2709144850652833
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Hypertension,22642,4263,1.00 [0.95-1.05],0.9679066109224256
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Hypertension, essential",22649,4270,1.00 [0.95-1.05],0.9445191011433988
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Hypertension, portal",23691,47,0.83 [0.46-1.51],0.5492465297385278
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",18456,77,1.26 [0.94-1.71],0.125861893850815
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,18419,40,0.89 [0.48-1.65],0.714178987050112
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Hypotension,23756,587,0.92 [0.79-1.07],0.2640019866691829
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,23375,56,1.36 [1.00-1.85],0.0526299905745316
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",23348,1300,0.94 [0.85-1.04],0.2215086397769346
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23645,275,1.01 [0.82-1.24],0.9100005179791948
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Left bundle-branch block,21710,179,0.98 [0.76-1.28],0.9046320126392432
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23620,519,0.95 [0.81-1.12],0.53425025786505
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22469,421,0.86 [0.71-1.05],0.1390042424026485
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23793,102,0.87 [0.59-1.29],0.5016342626468784
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23829,179,0.97 [0.74-1.27],0.826352651708758
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Oesophageal varices,22720,31,0.70 [0.31-1.59],0.3978050393449196
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other aneurysm,23181,43,0.51 [0.23-1.14],0.1000961491812787
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other arrhythmias,21753,222,0.98 [0.77-1.24],0.8392352749162442
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,23199,61,0.93 [0.58-1.49],0.7578564310400979
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23265,127,1.01 [0.75-1.37],0.924746757902383
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other diseases of pericardium,21640,109,1.13 [0.85-1.50],0.395521824967212
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other disorders of veins,22752,63,0.79 [0.47-1.34],0.3884946848155597
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22735,46,1.21 [0.81-1.81],0.3541042542281518
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,23157,32,0.94 [0.49-1.82],0.8616102732449132
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22769,80,1.11 [0.80-1.54],0.5173723282142887
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,22043,512,0.93 [0.79-1.10],0.4008355968075814
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,23207,38,1.06 [0.63-1.78],0.830110274295403
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23441,303,0.98 [0.80-1.20],0.8491096418077114
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23453,133,1.23 [0.97-1.55],0.0901000563635112
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",23328,203,0.79 [0.58-1.06],0.1151277754767821
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16340,209,0.95 [0.74-1.22],0.70563457703875
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Peripheral artery disease,23298,181,0.81 [0.59-1.10],0.1747573706932862
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22904,215,0.84 [0.64-1.11],0.2129166260895396
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Pulmonary embolism,23608,288,0.96 [0.78-1.18],0.6838476621914135
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23804,278,0.90 [0.72-1.14],0.3883371041061145
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Right bundle-branch block,21677,146,0.72 [0.49-1.04],0.0813044126302423
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Secondary right heart disease,23450,130,1.24 [0.98-1.57],0.06975736165216
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,23227,102,1.15 [0.87-1.54],0.3269912764092165
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23639,320,1.05 [0.87-1.26],0.6118479539750232
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23617,352,1.03 [0.86-1.23],0.7278306719723098
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,23355,48,0.91 [0.54-1.53],0.7188054523439553
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,23186,49,1.33 [0.94-1.88],0.1083657865989923
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Transient ischemic attack,23487,117,0.76 [0.52-1.13],0.1811191903763876
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23258,157,0.98 [0.74-1.30],0.8930994048803345
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Varicose veins,22948,259,0.93 [0.74-1.17],0.5447428986191263
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,23149,47,1.22 [0.83-1.77],0.311035690713162
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Venous thromboembolism,23689,450,0.89 [0.74-1.06],0.2008051257187121
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23697,323,0.99 [0.81-1.20],0.8937083746063104
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21215,1222,1.03 [0.93-1.13],0.5931334051528661
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,Any mental disorder,23183,3190,0.98 [0.93-1.04],0.5825488078414438
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23642,374,1.01 [0.85-1.20],0.9384703497041764
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",21458,1465,0.96 [0.88-1.05],0.3710341725526351
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",20067,74,0.90 [0.58-1.40],0.6397472048715718
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,Smoking dependency,23358,1333,1.01 [0.92-1.11],0.8458194824169286
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21521,1528,1.00 [0.92-1.08],0.9305377528008448
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,Vascular dementia,23744,15,0.93 [0.69-1.24],0.607303448917481
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Alzheimer disease,23843,63,1.01 [0.67-1.54],0.9533924535117662
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Bell's palsy,22380,67,1.03 [0.69-1.55],0.8698216795465108
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22735,422,1.17 [1.02-1.34],0.0226094215677862
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Cerebral cysts,23532,178,1.10 [0.88-1.38],0.4022582296511821
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23769,195,1.03 [0.81-1.31],0.8214260228197987
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23714,22,1.15 [0.63-2.10],0.6458049980838445
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23833,43,0.69 [0.34-1.39],0.3013237082869653
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23405,51,1.23 [0.85-1.80],0.2714104104619428
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Epilepsy,22502,227,0.89 [0.70-1.15],0.3761205695722504
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23421,1146,0.97 [0.87-1.07],0.5096229074442601
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23818,167,1.04 [0.81-1.35],0.7382674349765592
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Falls/tendency to fall,23402,1424,1.02 [0.93-1.11],0.6868054730875502
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Generalized epilepsy,23521,49,1.23 [0.83-1.81],0.3051350540942778
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Hemiplegia,23717,143,1.08 [0.83-1.41],0.5844269843184101
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Hydrocephalus,23397,43,0.84 [0.45-1.53],0.561935939715032
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23821,59,0.72 [0.40-1.29],0.2645687590424386
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Lesion of plantar nerve,22383,70,1.32 [0.99-1.74],0.0556221559468002
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,22386,73,0.54 [0.29-0.98],0.0440365730237334
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Memory loss,23713,64,1.01 [0.67-1.54],0.9449783010647904
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Migraine,22633,358,1.09 [0.93-1.28],0.2767248572902456
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23769,324,1.14 [0.97-1.33],0.1068210301653186
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Motor neuron disease,17320,91,0.98 [0.67-1.42],0.9106455359387406
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23652,129,1.21 [0.96-1.52],0.1111167790232769
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23304,991,1.10 [1.00-1.21],0.0483570050791427
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Neurological diseases,22570,2622,1.05 [0.99-1.12],0.1095238990471544
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23756,64,1.03 [0.68-1.57],0.8827896372116307
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22648,335,1.02 [0.85-1.23],0.8311725105671226
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23779,199,0.95 [0.74-1.23],0.7061234321924612
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19882,276,1.14 [0.95-1.36],0.1549461833326148
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23406,52,1.11 [0.72-1.69],0.6356977534395187
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other disorders of nervous system,23455,101,0.84 [0.57-1.26],0.4029394238180145
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23724,73,0.91 [0.59-1.40],0.6613422197649758
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other facial nerve disorders,22397,84,0.98 [0.66-1.44],0.9027900822188312
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other headache syndromes,22331,56,0.83 [0.49-1.40],0.4798946076715269
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other neurological diseases,23738,384,1.00 [0.84-1.19],0.9663198643366888
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other sleep disorders,22776,501,0.89 [0.75-1.06],0.1829870819737757
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Parkinson's disease,23832,75,1.20 [0.87-1.65],0.2692028684437084
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23409,55,1.08 [0.72-1.62],0.6919496568687314
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Restless leg syndrome,23842,34,0.69 [0.32-1.51],0.3550250531054847
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Sleep apnoea,23631,437,0.94 [0.79-1.11],0.4788060978093246
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Small fibre neuropathy,23610,30,0.85 [0.41-1.78],0.6749507925699718
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23828,117,0.91 [0.64-1.28],0.5741943602014361
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22341,28,1.16 [0.67-2.00],0.5950766191900054
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23843,64,1.00 [0.65-1.52],0.9829810481337378
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23732,14,0.93 [0.69-1.25],0.6180282768458774
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23421,35,0.92 [0.49-1.72],0.7958388546187316
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23530,186,0.90 [0.69-1.19],0.4752941864007043
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23770,171,0.93 [0.69-1.25],0.627549077426838
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,23196,32,0.92 [0.48-1.74],0.7939067247830525
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23230,66,1.09 [0.74-1.59],0.6619922498223867
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23764,29,0.63 [0.26-1.53],0.30229115471289
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23675,57,0.82 [0.47-1.41],0.4686936058677433
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1452,32,0.87 [0.43-1.78],0.7102746706992368
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1723,68,0.81 [0.50-1.32],0.3930821416492583
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23461,75,1.04 [0.72-1.52],0.8298590030887341
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23736,539,1.04 [0.90-1.20],0.6160563266230414
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23578,414,0.97 [0.82-1.15],0.7124536657287144
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23285,121,0.96 [0.70-1.32],0.7987919639321747
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23763,419,0.94 [0.79-1.12],0.4823982735259059
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23835,48,0.84 [0.47-1.50],0.5610527625633757
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23695,351,1.01 [0.84-1.21],0.914665453775308
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23807,189,0.86 [0.65-1.15],0.3052588389784497
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23785,114,0.85 [0.59-1.24],0.4060793246936132
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,23179,15,1.34 [0.73-2.47],0.3384892829657404
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,23189,25,0.87 [0.40-1.91],0.7353310931569118
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,23194,30,1.02 [0.55-1.89],0.9447413318050164
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23801,337,0.94 [0.77-1.15],0.5649038782549964
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23548,84,1.06 [0.75-1.51],0.7315710613593278
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23365,21,1.20 [0.67-2.17],0.5406072254547252
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23679,61,0.90 [0.55-1.47],0.6780158735256892
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23748,130,0.83 [0.58-1.18],0.3050975253839124
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23487,143,1.02 [0.77-1.35],0.8857307758525002
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23733,62,0.98 [0.62-1.53],0.9134668759029104
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23683,219,0.90 [0.70-1.17],0.4461218558255049
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23483,97,1.05 [0.76-1.46],0.7637656503303575
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,23239,940,1.03 [0.92-1.15],0.621571051447759
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23727,109,0.86 [0.59-1.25],0.4233249421067544
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23821,101,1.10 [0.81-1.50],0.5423572302395844
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23392,228,0.93 [0.73-1.18],0.5530360328743351
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23653,35,1.11 [0.67-1.85],0.6759472622128965
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23819,32,0.88 [0.44-1.75],0.7139339310983532
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,23200,36,1.52 [1.13-2.05],0.0060473287247753
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23265,101,1.04 [0.75-1.42],0.8275824695946064
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,23255,58,1.13 [0.75-1.70],0.5558713853003323
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23394,50,0.80 [0.45-1.41],0.4349360263695316
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",23244,47,0.91 [0.52-1.57],0.72598388852665
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23510,46,0.68 [0.35-1.33],0.2569769332299915
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23544,80,0.74 [0.45-1.23],0.2442084035563803
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,23240,76,0.76 [0.46-1.25],0.2747423066369251
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,23300,103,1.40 [1.13-1.74],0.0024884956369981
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,23226,29,1.08 [0.59-1.96],0.8078193317527258
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23012,713,1.01 [0.89-1.15],0.8801306098709192
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,23208,44,0.99 [0.59-1.66],0.974414895725817
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23654,268,0.95 [0.76-1.19],0.6587644254688882
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23416,30,0.67 [0.28-1.60],0.3699822106491558
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23493,107,1.15 [0.87-1.52],0.3270739011439574
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23664,55,0.87 [0.52-1.47],0.6045892218664084
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23805,81,0.80 [0.51-1.26],0.3339276573433501
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23737,126,0.78 [0.53-1.13],0.1849137832552638
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23658,49,0.80 [0.44-1.44],0.4478049119573354
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23659,50,1.00 [0.63-1.60],0.9985072605694556
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23757,459,1.10 [0.95-1.27],0.1888817132224103
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23585,287,1.03 [0.85-1.26],0.7514055339664493
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,23382,84,1.39 [1.09-1.79],0.0083066321118213
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VIII Diseases of the ear and mastoid process,Tinnitus,23364,66,1.45 [1.13-1.86],0.0032787225145585
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Acute pharyngitis,23590,69,0.92 [0.59-1.42],0.7039335750555473
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23729,208,0.95 [0.74-1.21],0.6654257774622198
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23577,56,1.01 [0.64-1.58],0.9668706894524154
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,All influenza,22720,68,0.97 [0.63-1.48],0.88247478398768
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22719,67,0.99 [0.65-1.51],0.9588080141221036
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Allergic asthma (mode),17615,118,1.09 [0.82-1.46],0.5417003985874312
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Allergic rhinitis,23718,274,0.78 [0.60-1.00],0.0528642215641886
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18899,1530,1.05 [0.96-1.14],0.2902979750935974
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18999,1502,1.04 [0.96-1.13],0.3263349996450738
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23597,84,0.87 [0.57-1.33],0.5258683550052596
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",22701,49,0.89 [0.52-1.54],0.6834046326398453
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Bronchiectasis,21192,156,0.94 [0.71-1.25],0.6782801848662499
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",21071,35,0.38 [0.14-1.00],0.0497323439046513
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,23078,2042,1.00 [0.93-1.08],0.9027655631520098
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22550,59,0.57 [0.30-1.10],0.0950337503242256
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Chronic sinusitis,22635,144,1.03 [0.78-1.35],0.8537664002958179
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23759,627,0.91 [0.79-1.06],0.2144456195086305
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Deviated nasal septum,22609,118,0.93 [0.67-1.31],0.6902769821441463
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22158,3688,0.98 [0.93-1.04],0.5045012739163739
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22829,338,0.94 [0.78-1.15],0.5614881599407875
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Early onset COPD,23582,450,0.91 [0.77-1.08],0.2845224746911038
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Emphysema,21194,158,0.98 [0.74-1.30],0.909593001772386
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22715,97,1.01 [0.72-1.42],0.9610626150007378
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Influenza and pneumonia,23685,1033,1.01 [0.91-1.12],0.8357261143473632
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Interstitial lung disease,22737,119,1.01 [0.74-1.37],0.9740090064512564
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Later onset COPD,22573,177,0.90 [0.68-1.19],0.4609968408468323
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23836,135,1.16 [0.90-1.49],0.2463723956789338
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Nasal polyp,22595,104,0.81 [0.54-1.21],0.2930077762251222
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23651,558,0.93 [0.80-1.09],0.3622078061903581
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Other diseases of pleura,23684,1090,0.94 [0.85-1.05],0.3081466646931018
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23274,783,0.91 [0.79-1.04],0.1482777307207763
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Other pleural conditions,22627,33,1.21 [0.75-1.95],0.4272386989145266
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23790,175,1.04 [0.81-1.33],0.7665216339637291
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23768,741,0.87 [0.76-1.01],0.062376873788257
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Pleural effusion,23120,526,1.04 [0.91-1.20],0.5472492094652233
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Pleural plaque,22641,47,0.79 [0.43-1.48],0.4705748445001707
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23500,848,1.02 [0.91-1.14],0.7915956830995071
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23819,118,1.15 [0.88-1.51],0.2957283484540331
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Pneumothorax,22650,56,0.98 [0.61-1.57],0.93122341189519
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Pollen allergy,23814,235,0.82 [0.63-1.07],0.1517266318755653
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Pulmonary oedema,23651,36,0.82 [0.42-1.62],0.5751283745094653
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Respiratory insufficiency,17528,31,1.11 [0.64-1.94],0.7110185152159815
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23631,538,0.94 [0.80-1.10],0.4354265724782598
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22765,274,0.78 [0.60-1.00],0.0495917359967848
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Viral pneumonia,22816,164,0.87 [0.64-1.18],0.3786911328904339
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23613,140,0.87 [0.62-1.21],0.4091912595006335
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13724,84,0.77 [0.48-1.26],0.2976042340385485
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,18233,57,0.81 [0.47-1.40],0.4579649264502212
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Acute appendicitis,23669,130,0.95 [0.70-1.30],0.7541981730648684
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Acute gastritis,19054,59,1.50 [1.16-1.95],0.0021372030834116
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Acute pancreatitis,22447,148,0.92 [0.68-1.25],0.6083764345435796
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Acute peritonitis,23457,61,0.98 [0.62-1.52],0.9122103514129016
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Alcoholic liver disease,23174,73,1.15 [0.82-1.62],0.409831149944056
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Barrett oesophagus,19302,307,1.14 [0.96-1.36],0.1286923201474046
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22345,46,0.64 [0.31-1.30],0.2148634232057282
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23485,46,0.64 [0.31-1.30],0.2161705494340381
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Cholecystitis,22450,151,1.00 [0.76-1.32],0.9849164625800458
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Cholelithiasis,23114,815,1.00 [0.89-1.12],0.9782544690066098
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Chronic gastritis,19210,215,1.09 [0.88-1.35],0.4399436308307747
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Chronic pancreatitis,22335,36,0.56 [0.24-1.32],0.1870848011099343
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23716,72,0.93 [0.60-1.44],0.7426693945082132
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Coeliac disease,22596,96,1.33 [1.05-1.69],0.0171235810221825
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Collagenous colitis,22477,47,0.53 [0.25-1.12],0.0963117443855155
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23673,180,1.14 [0.92-1.42],0.2371628902382401
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Constipation,23656,1004,0.98 [0.88-1.09],0.669405847911732
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Crohn disease,22511,81,0.72 [0.44-1.17],0.1868407836869223
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23534,53,0.92 [0.55-1.52],0.7370014822436473
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Crohn's disease NAS,22507,77,0.72 [0.44-1.19],0.2038241280558426
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Dental caries,23117,229,1.17 [0.97-1.41],0.0936788168944219
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22034,1561,1.08 [1.00-1.17],0.0584987778704109
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diseases of appendix,23706,167,0.98 [0.75-1.27],0.8662804879152415
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diseases of liver,23736,635,0.88 [0.75-1.02],0.0940668616071687
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",22326,3331,1.09 [1.03-1.15],0.0019983978050959
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23416,528,1.12 [0.99-1.28],0.0784184483252929
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diseases of peritoneum,23768,372,0.83 [0.67-1.01],0.0678093826331103
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23003,115,1.00 [0.73-1.38],0.9755495069814129
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diseases of salivary glands,22864,61,1.10 [0.74-1.63],0.6524055750779774
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diseases of the digestive system,23591,1091,1.03 [0.93-1.14],0.5988028415944513
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diseases of tongue,22869,107,1.29 [1.02-1.64],0.0369121077940411
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23395,1096,0.97 [0.87-1.07],0.5100898160316192
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20289,2113,1.00 [0.92-1.07],0.9119091085056116
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Duodenal ulcer,19125,130,1.10 [0.83-1.45],0.5185782852156944
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23781,101,0.95 [0.66-1.37],0.7911013964991891
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23727,72,1.13 [0.81-1.60],0.4713273834547812
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23191,90,0.81 [0.52-1.26],0.3526730072681214
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,18330,154,1.05 [0.81-1.37],0.69835980051052
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Functional dyspepsia,19438,443,1.02 [0.87-1.20],0.768490162492152
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Gastric ulcer,19240,245,0.95 [0.75-1.20],0.6708055544800129
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,20953,1958,1.08 [1.00-1.16],0.0439058790952415
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,19353,358,1.08 [0.91-1.28],0.3812289831038795
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19402,6915,1.05 [1.01-1.09],0.0198928768020717
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,GI-bleeding,23377,877,1.00 [0.89-1.12],0.9654757598719924
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22950,62,1.21 [0.88-1.67],0.2440826878040726
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,18957,1097,0.92 [0.82-1.03],0.1434791463132392
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23147,46,0.86 [0.48-1.54],0.6072892220381894
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Hernia,22834,2361,1.02 [0.95-1.09],0.6471753160690386
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Impacted teeth,23736,67,1.21 [0.87-1.68],0.2669272750525798
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Impaction of intestines,18208,32,0.51 [0.21-1.28],0.1525882712218922
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Inguinal hernia,21069,596,1.02 [0.88-1.18],0.8146812972941766
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",20543,70,1.26 [0.89-1.79],0.1936082549879579
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,18239,63,0.93 [0.58-1.48],0.7567763205857504
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Intestinal malabsorption,22616,116,1.31 [1.05-1.63],0.0181590595603656
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Irritable bowel syndrome,18682,506,0.95 [0.82-1.12],0.5595016562832024
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23818,328,0.73 [0.58-0.93],0.0122309043512219
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23037,607,1.07 [0.94-1.22],0.2837458199815111
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23196,766,1.05 [0.93-1.17],0.4367992581181606
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Oesophageal obstruction,19122,127,0.97 [0.70-1.34],0.8495205286327769
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Oesophagitis,19420,425,1.12 [0.96-1.30],0.1549238676943311
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23803,116,0.98 [0.71-1.34],0.8867516573632754
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20516,43,1.06 [0.65-1.74],0.8030714971057729
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,19301,1125,0.96 [0.87-1.07],0.4873795815168525
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22468,169,0.92 [0.69-1.22],0.544395933300534
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of gallbladder,22436,137,1.00 [0.75-1.32],0.9842725374721032
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of intestine,19483,1307,0.97 [0.88-1.07],0.587032716423902
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of intestines,22406,4230,1.00 [0.94-1.05],0.8836877809595919
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22866,168,1.03 [0.80-1.32],0.8339544845613681
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of liver,23608,507,0.83 [0.69-0.99],0.0372646920125652
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of oesophagus,19461,466,1.10 [0.95-1.27],0.1901924181852041
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of pancreas,22373,74,0.87 [0.56-1.35],0.5360323619687248
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23720,324,0.79 [0.63-0.99],0.041169859510994
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,19657,662,1.10 [0.97-1.24],0.1375692336652979
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23391,891,0.99 [0.88-1.11],0.846686590245847
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23035,147,1.15 [0.90-1.46],0.2619369684558171
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other functional intestinal disorders,19225,1049,1.00 [0.90-1.11],0.9845285956716264
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),20514,1519,1.10 [1.01-1.19],0.0240979467639295
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23169,68,0.99 [0.66-1.49],0.97424812549182
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23095,665,1.04 [0.92-1.18],0.5504530556776457
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",18383,207,0.92 [0.71-1.19],0.5416519532477962
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23712,83,1.16 [0.85-1.58],0.3495997051646967
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,18482,306,0.95 [0.77-1.17],0.6368881293148609
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22620,120,1.04 [0.78-1.40],0.7803078354509196
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Recurring oral aphthae,23833,56,0.90 [0.55-1.48],0.6731138318052254
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22902,118,1.07 [0.79-1.43],0.6633635179180708
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Toxic colitis,22453,23,1.06 [0.54-2.05],0.873659269717658
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Ulcer of oesophagus,19160,165,1.03 [0.79-1.34],0.8131462998267933
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Ulcerative colitis,22563,133,1.06 [0.80-1.39],0.6895479852787123
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22545,115,0.82 [0.56-1.20],0.3116221374574666
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Umbilical hernia,20710,237,0.82 [0.63-1.07],0.1443269846905632
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,18270,94,1.24 [0.95-1.63],0.1163919678364546
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Ventral hernia,20674,201,0.94 [0.73-1.22],0.6360257595757809
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Volvulus,18234,58,0.97 [0.61-1.54],0.8867836887484642
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23801,132,1.24 [0.98-1.56],0.0699515393129378
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23610,72,0.87 [0.55-1.37],0.5547122764924324
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22571,129,0.84 [0.60-1.18],0.3137269980069894
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23270,475,0.93 [0.79-1.10],0.3853715713763729
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22976,181,1.11 [0.89-1.39],0.3465726332790341
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22591,149,1.08 [0.85-1.39],0.5242169954931476
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23620,206,1.13 [0.92-1.38],0.250140478918297
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23756,342,1.12 [0.96-1.32],0.1483841137946056
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23450,36,0.88 [0.47-1.66],0.6904637612910209
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22554,2217,1.01 [0.94-1.08],0.803557859271725
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23435,372,1.02 [0.87-1.21],0.7770687249178232
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23327,264,1.13 [0.94-1.35],0.1897960511599441
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23485,690,0.98 [0.86-1.11],0.7429759025274669
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23831,40,0.67 [0.33-1.38],0.2767282373067275
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,22497,55,0.50 [0.25-1.02],0.0572078195570155
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23097,34,0.40 [0.15-1.06],0.0650321956302672
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23614,200,1.15 [0.94-1.41],0.1629143521921485
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22690,248,1.11 [0.92-1.34],0.2898464485269151
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,22475,33,0.90 [0.47-1.74],0.7527405542006261
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23768,63,1.29 [0.95-1.75],0.1055947825261977
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22915,120,0.83 [0.57-1.19],0.3124597177181706
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23671,133,0.99 [0.74-1.34],0.9691532618053796
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23438,24,0.99 [0.51-1.93],0.9705824024125516
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,22486,44,0.92 [0.53-1.61],0.7789452720437002
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23396,954,0.96 [0.86-1.07],0.4735215525346278
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22720,278,1.06 [0.88-1.28],0.5442582631267787
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,22479,37,0.85 [0.45-1.62],0.6225946232126586
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23769,231,0.94 [0.74-1.19],0.5856793274502702
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23468,54,1.16 [0.78-1.71],0.4585462035964496
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23727,189,0.98 [0.76-1.26],0.8712196451293986
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23816,147,1.23 [0.99-1.53],0.061257455211715
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22550,108,0.84 [0.58-1.22],0.3525350054177787
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22605,163,1.05 [0.82-1.35],0.6892490686097859
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23810,141,1.22 [0.98-1.53],0.0807615397557419
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",22557,115,0.78 [0.52-1.16],0.2164802448333818
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23812,107,1.20 [0.92-1.55],0.1802366516020922
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20893,114,1.06 [0.78-1.43],0.7260720162035785
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,22222,4043,0.98 [0.93-1.04],0.5828407565108262
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,21056,2877,1.00 [0.94-1.07],0.9251668398987224
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20861,82,1.24 [0.93-1.67],0.144859131415891
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,21372,135,1.03 [0.77-1.37],0.8429812743155458
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,21380,143,0.92 [0.67-1.25],0.5755297544101852
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23636,103,0.93 [0.65-1.33],0.6766379612606015
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",21279,42,0.75 [0.38-1.47],0.399599347302918
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,18848,669,1.04 [0.91-1.18],0.5679699553338624
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23787,115,0.75 [0.50-1.12],0.1548878936463924
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21491,254,0.79 [0.61-1.03],0.0803246884198911
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,20813,5403,0.99 [0.95-1.04],0.7332218484202655
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22624,91,0.97 [0.67-1.42],0.880440051742859
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20881,102,0.99 [0.70-1.40],0.9373426254737804
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21314,535,1.00 [0.86-1.16],0.9783242192022786
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,23059,1822,0.97 [0.89-1.05],0.4321493555989036
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20977,198,1.08 [0.86-1.35],0.5279313126088271
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,21039,260,1.18 [1.00-1.40],0.049986171552151
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20915,136,1.07 [0.82-1.41],0.6098040417070252
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23373,34,1.03 [0.59-1.79],0.921154336351153
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,19324,1145,1.00 [0.90-1.10],0.9749377859563272
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18509,330,0.76 [0.59-0.97],0.0283991236195996
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23793,320,0.78 [0.61-1.00],0.04749938574146
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18246,67,0.90 [0.57-1.42],0.6457700724045079
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18481,302,0.97 [0.79-1.18],0.7409205570605785
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,21067,288,1.06 [0.88-1.28],0.5251594912205254
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,18849,670,0.99 [0.86-1.13],0.8576738453297392
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,21262,25,0.85 [0.39-1.85],0.6754391047614117
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21728,491,0.96 [0.82-1.12],0.6009625766544433
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,21487,250,1.06 [0.86-1.29],0.5910528959136983
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,18799,620,0.99 [0.87-1.14],0.9327100060126858
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20849,70,0.99 [0.65-1.50],0.948813379380384
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20832,53,1.37 [0.99-1.88],0.0548017311072821
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,22584,51,0.52 [0.24-1.09],0.0842431912589225
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23552,1019,1.06 [0.96-1.17],0.2567901251962806
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23111,578,1.13 [1.00-1.28],0.0424369013099681
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23740,303,1.04 [0.86-1.25],0.7119312785071501
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,19732,1553,1.00 [0.92-1.09],0.9351978311107824
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,18246,67,0.72 [0.42-1.24],0.236399974356891
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20849,70,1.47 [1.15-1.88],0.001988663722268
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,18205,26,0.95 [0.46-1.95],0.8809763834630125
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18279,100,1.01 [0.72-1.41],0.9565553624687928
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22743,210,1.07 [0.86-1.33],0.5241289700945708
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,22748,215,1.04 [0.83-1.30],0.7361652537073694
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23810,75,0.86 [0.55-1.34],0.503688399972527
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22606,1369,0.98 [0.89-1.07],0.6207999679312441
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20887,108,1.14 [0.86-1.51],0.3511627296507297
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18285,106,0.86 [0.59-1.26],0.4486134706177503
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21795,558,1.03 [0.89-1.18],0.7135922762251365
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,19970,1791,0.97 [0.90-1.06],0.5095072169629391
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23390,51,1.02 [0.65-1.62],0.9174274523807604
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23818,69,0.78 [0.47-1.30],0.3436608380236341
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20847,68,1.10 [0.75-1.60],0.6285349031492166
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21743,964,1.04 [0.93-1.16],0.4806267580045363
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20837,58,1.15 [0.78-1.69],0.4816841633828855
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,19154,975,1.00 [0.89-1.11],0.938052665681316
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22630,97,1.16 [0.87-1.54],0.3243994266736345
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20837,58,0.62 [0.33-1.17],0.1373570769771386
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,21340,103,1.14 [0.86-1.52],0.3564418769685189
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21124,345,0.99 [0.82-1.19],0.911118312842874
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23524,185,1.27 [1.06-1.53],0.010349080329109
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21652,415,0.98 [0.82-1.16],0.7806778438859334
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23749,288,1.04 [0.86-1.25],0.6983740115655921
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23827,33,1.36 [0.92-2.01],0.1234940158470277
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20961,182,0.97 [0.75-1.27],0.8406033547453902
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19097,537,0.88 [0.74-1.04],0.12198473599809
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21212,433,0.99 [0.83-1.17],0.8658639758902613
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20926,147,1.04 [0.79-1.38],0.7672747985196279
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",18213,34,1.00 [0.56-1.79],0.9874761602652656
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19713,1534,1.00 [0.91-1.09],0.9309445394882586
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18569,390,0.98 [0.82-1.17],0.8583491074652942
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23413,74,1.39 [1.08-1.79],0.0111990976083684
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23778,43,0.95 [0.55-1.62],0.8405716165179853
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",22438,26,1.13 [0.64-1.98],0.6692509131843125
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,18250,71,0.85 [0.53-1.37],0.5041795578360013
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,21319,82,0.57 [0.33-1.00],0.0481843833779967
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18486,307,1.03 [0.85-1.25],0.7486531499989617
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,21018,239,1.04 [0.84-1.29],0.6954786729206079
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,21430,193,0.90 [0.69-1.18],0.441093940030979
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,21331,94,0.90 [0.61-1.33],0.6037693313140549
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,20133,41,0.70 [0.35-1.40],0.3111916379511064
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23830,36,1.38 [0.96-1.99],0.0859855506103713
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21303,524,1.02 [0.88-1.18],0.842456850666307
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],23417,78,1.11 [0.80-1.55],0.5291181945836552
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22901,2122,1.02 [0.95-1.10],0.5892580135071488
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20879,100,1.08 [0.78-1.48],0.6547240203367741
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21554,317,0.93 [0.76-1.15],0.5073986159484324
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22596,166,1.05 [0.82-1.35],0.6794556311039046
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,21369,132,0.75 [0.51-1.09],0.1348594954725348
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22166,929,0.97 [0.86-1.08],0.5616051837598306
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21840,603,0.93 [0.80-1.08],0.359212399114852
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20818,39,1.72 [1.34-2.21],2.2243187699455537e-05
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23480,141,1.11 [0.86-1.43],0.4092218122229768
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20914,135,0.94 [0.69-1.28],0.6971400901550902
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20833,54,1.18 [0.81-1.71],0.3998354911479767
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),18211,32,1.04 [0.57-1.89],0.9064350341569682
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Acute renal failure,23392,722,0.91 [0.79-1.05],0.2098163860182305
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9712,64,1.14 [0.81-1.61],0.4429645853965362
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,12887,70,1.05 [0.73-1.52],0.7843401324276555
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23589,272,0.81 [0.63-1.04],0.0950125185018535
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23373,56,0.85 [0.49-1.46],0.5524627364830637
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23217,547,1.05 [0.91-1.20],0.5329680259078389
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23686,17,0.75 [0.27-2.15],0.5969973990173238
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23699,159,1.04 [0.80-1.35],0.7832792085313496
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Cystitis,21906,133,1.03 [0.77-1.36],0.8592628042593601
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Dialysis,22713,43,0.80 [0.42-1.52],0.4889955189348005
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10297,979,1.00 [0.89-1.12],0.9969062521481352
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Disorders of breast,12987,170,0.97 [0.75-1.25],0.79329570982856
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Endometriosis,9763,115,1.18 [0.92-1.51],0.1862462132908903
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",9978,330,0.99 [0.82-1.18],0.8795559448502661
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Female genital prolapse,10026,378,1.00 [0.84-1.18],0.9581151618024002
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20109,3652,1.02 [0.97-1.08],0.4558291041680419
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23725,56,1.06 [0.69-1.63],0.7812184840813161
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Hydrocele,9389,71,0.69 [0.40-1.21],0.196344164604366
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Hydronephrosis,22590,190,0.79 [0.58-1.07],0.1314095589938327
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9970,652,1.09 [0.96-1.23],0.2005823914271323
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,12873,208,0.92 [0.72-1.17],0.4806911485112451
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),9409,91,1.06 [0.74-1.51],0.7495939721436637
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Irregular menses,12888,106,1.08 [0.81-1.44],0.5986421056226789
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Menorrhagia,9905,257,0.94 [0.76-1.17],0.6011168529422604
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,21830,57,1.19 [0.83-1.70],0.3483260285675068
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10859,1211,1.06 [0.97-1.16],0.2152780810755103
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,9365,47,1.29 [0.88-1.89],0.183714388713974
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9731,83,0.99 [0.70-1.42],0.973799311929942
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23834,34,1.35 [0.90-2.03],0.152862859432395
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23838,37,0.89 [0.48-1.63],0.6957630716166976
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,23090,1317,1.00 [0.91-1.10],0.9647935970291024
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,22192,419,1.12 [0.97-1.30],0.122768644779645
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other disorders of breast,12869,52,0.97 [0.61-1.54],0.8816347630128333
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23797,257,1.14 [0.94-1.37],0.1792080474780196
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,9453,135,0.83 [0.58-1.19],0.3011498080681818
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other disorders of penis,9422,104,0.82 [0.54-1.24],0.3531894482856106
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,9382,64,0.99 [0.63-1.55],0.9695851670424606
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23810,45,0.63 [0.31-1.27],0.1944317415971263
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22740,967,0.96 [0.86-1.08],0.4938977761457725
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,12771,106,1.01 [0.74-1.37],0.966527100700111
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9716,68,0.95 [0.63-1.45],0.827387086786852
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9845,197,1.21 [1.00-1.46],0.0475868837822968
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9700,52,1.17 [0.80-1.72],0.4041560701472354
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9738,90,0.87 [0.58-1.31],0.5078555510572458
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,22621,221,0.76 [0.57-1.01],0.0605148118886577
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23627,87,1.12 [0.81-1.56],0.4825099994584816
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9806,158,1.14 [0.91-1.44],0.245919198569868
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9716,68,0.82 [0.51-1.31],0.4005742535455746
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,10006,358,1.00 [0.84-1.19],0.96833611017508
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9705,57,0.99 [0.64-1.53],0.9553190005065226
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9965,317,1.06 [0.90-1.27],0.4789304940030842
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23710,41,0.55 [0.25-1.22],0.142353721868407
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",9409,91,0.54 [0.31-0.93],0.027013320933453
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23687,1287,0.96 [0.87-1.06],0.4260962980069691
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",22522,122,0.97 [0.71-1.32],0.8468493850560357
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,22726,56,0.75 [0.42-1.34],0.3302176554354094
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23379,62,0.74 [0.42-1.29],0.2875005319592161
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Urethral stricture,21918,145,0.92 [0.68-1.26],0.6141716403566064
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Urolithiasis,23647,330,0.86 [0.69-1.07],0.1713196967560828
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Uterine polyps,9734,86,0.99 [0.69-1.42],0.9666285319884091
